| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 925-929, Copyright © 1989 by Endocrine Society
ARTICLES |
PE Walton and MJ Cronin
Genentech, Inc., South San Francisco, California 94080.
Anabolic proteins such as pituitary GH enhance the function of several immune cell types. The converse could also exist, that is communication from the immune cells to GH-producing somatotrophs. To test this hypothesis, tumor necrosis factor-alpha (TNF-alpha), a product of activated macrophages, was exposed to cultured rat pituitary cells, and GH release was monitored. TNF alpha inhibited basal and GH-releasing hormone-stimulated GH accumulation, with IC50 values of 170 U/ml (5.2 ng/ml) and 50 U/ml (1.5 ng/ml), respectively. This inhibition was first measured after 6 h of TNF alpha treatment, continued for at least 3 days, and was reversible. A number of measurements (e.g. trypan blue exclusion, chromium release, and GH cell content) yielded no signs of cytotoxicity to explain the inhibition. We conclude that TNF alpha can reduce basal and stimulated pituitary GH release in vitro.
This article has been cited by other articles:
![]() |
C. Kakinuma, Y. Hamada, Y. Futamura, C. Kuwayama, A. Shimoi, and Y. Shibutani Human Natural Tumor Necrosis Factor {alpha} Induces Multiple Endocrine and Hematologic Disorders in Rats Toxicol Pathol, July 1, 1999; 27(4): 402 - 411. [Abstract] [PDF] |
||||
![]() |
W. Liao, M. Rudling, and B. Angelin Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor I on the Biological Activities of Endotoxin in the Rat Endocrinology, January 1, 1997; 138(1): 289 - 295. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |